Medication info
NPIANG Duo Tablets 12.5/500 mg (Empagliflozin, Metformin Hydrochloride)

NPIANG Duo Tablets 12.5/500 mg (Empagliflozin, Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Empagliflozin›12.5mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
A two-sided, convex, oval film-coated tablet with a light brownish purple color.
Packaging
10 tablets/box [(10 tablets/PTP × 1)], 60 tablets/box [(10 tablets/PTP × 6)], 30 tablets/bottle, 60 tablets/bottle
Approval status
Active

MFDS item code 202302662 · Approved 2023.09.06 · Insurance code 669908440

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; if this occurs, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is needed in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with empagliflozin and metformin as separate single-ingredient products. The maximum daily dose of metformin hydrochloride that may be given with this medicine is 1000 mg, administered as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Cautious Administration, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Receive This Medicine, item 2)). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Difficulty controlling blood sugar
  • type 2 diabetes
View approved original text

This medication is used to improve blood sugar control in adult patients with type 2 diabetes, in conjunction with dietary and exercise therapy. In particular, the combination of empagliflozin and metformin can effectively lower blood sugar levels. It can also be administered to patients with cardiovascular disease, but it is important to follow professional guidelines regarding this. Therefore, this medication is used to improve blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their current doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; if this occurs, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is needed in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with empagliflozin and metformin as separate single-ingredient products. The maximum daily dose of metformin hydrochloride that may be given with this medicine is 1000 mg, administered as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Cautious Administration, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Receive This Medicine, item 2)). Elderly patients In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Precautions

This medication helps control blood sugar levels. However, it may cause a rare side effect called lactic acidosis. Therefore, it should not be used in patients with poor kidney function or in cases of severe infection or dehydration. Additionally, caution is needed when used alongside other diabetes medications such as insulin or sulfonylureas, as hypoglycemia may occur. Kidney function should be regularly tested, and if kidney function deteriorates, this medication should be discontinued. This medication should also be temporarily stopped before and after surgeries or tests that involve iodine contrast agents. It is safer not to use this medication during pregnancy or breastfeeding. During treatment, patients should be cautious of dehydration or fluid loss, and if symptoms such as severe vomiting or diarrhea occur, consult a doctor. There may be symptoms of genital infections or urinary tract infections, so report any unusual symptoms immediately. Since vitamin B12 levels may decrease, regular blood tests should be performed if necessary. Alcohol can increase the risk of side effects, so excessive drinking should be avoided during treatment. Moreover, dosage adjustment and caution are necessary for elderly patients or those with weakened kidney function. Patients should closely monitor for symptoms of hypoglycemia, lactic acidosis, and ketoacidosis, and report any abnormalities to healthcare personnel immediately. Finally, this medication is not recommended for children or adolescents under 18 years of age.

Side effects

Severe lactic acidosis, severe hypoglycemia, hypoglycemia, urinary tract infection, genital infection, increased urination, decreased and deficiency of vitamin B12, ketoacidosis, lactic acidosis, reduced fluid volume, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, constipation, abnormal liver function tests, hepatitis, taste disturbances, itching, rash, urticaria, erythema, angioedema, dysuria, interstitial nephritis, thirst, increased serum lipids, increased blood creatinine, decreased glomerular filtration rate, nausea, discomfort in the gastrointestinal tract, chronic gastritis, constipation, gastritis, abdominal discomfort, anal incontinence, dry mouth, gastroesophageal reflux disease, oral discomfort, salivary gland pain, headache, sensory impairment, orthostatic dizziness, dizziness, cerebral infarction, weakness, chest discomfort, chest pain, ankle fracture, epicondylitis, facial bone fracture, musculoskeletal pain, myocardial infarction, insomnia, upper respiratory tract infection, soft tissue infection, pneumonia, vascular stent stenosis, vascular stent thrombosis, increased alanine aminotransferase, increased aspartate aminotransferase, ureterolithiasis, acute kidney injury, cervicitis, hypercholesterolemia, dyslipidemia, vitamin D deficiency, vulvar pruritus, benign prostatic hyperplasia, diabetic retinopathy, diplopia, hypertension, angina, unstable angina, anxiety, acute cholecystitis, autoimmune hepatitis, cholelithiasis, hepatitis, otalgia, orthostatic vertigo, vertigo, anemia, lymphadenopathy, hypothyroidism, thyroid nodule, diabetic foot, dermoid cyst, seborrheic dermatitis, atopic dermatitis, nummular eczema, heat rash, sebaceous gland hyperplasia, lumbar spinal canal stenosis, myalgia, limb pain, musculoskeletal chest pain, arthralgia, cervical spine stenosis, fibromyalgia, flank pain, fracture pain, muscle weakness, osteoarthritis, osteoporosis, rotator cuff syndrome, astigmatism, cataract, allergic conjunctivitis, blurred vision, corneal erosion, glaucoma, macular fibrosis, ocular discomfort, ocular congestion, pathological myopia, retinal detachment, retinal crystals, retinal vein occlusion, lamellar retinal detachment, eyelid swelling, visual impairment, vitreous floaters, vitreous hemorrhage, epistaxis, asthma, age-related dyspnea, wet cough, allergic rhinitis, residual phlegm, cough, skin laceration, contusion, rib fracture, concussion, corneal abrasion, fall, hand fracture, iliotibial band syndrome, open globe injury, pelvic fracture, road traffic accident, splenic injury, sternum fracture, palpitations, tachycardia, arteriosclerosis, deep vein thrombosis, diabetic vascular complications, peripheral arterial occlusive disease, insomnia, decreased appetite, somnolence, hyponatremia, weight loss, weight gain, abnormal ECG, decreased hemoglobin, increased hemoglobin, positive Helicobacter test, positive urinalysis for red blood cells, fever, facial swelling, chills, strange sensations, edema, pain, pain at the puncture site, blood glucose ≤ 70 ml/dL or treatment is needed, treatment-needed hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

A two-sided, convex, oval film-coated tablet with a light brownish purple color.

Package unit

10 tablets/box [(10 tablets/PTP × 1)], 60 tablets/box [(10 tablets/PTP × 6)], 30 tablets/bottle, 60 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.